Scale-Up Health 2024: Disruptive Trends in Healthcare & Life Sciences
By Rediff Money Desk, Mumbai Aug 11, 2024 15:12
Join industry leaders at Scale-Up Health 2024 in Mumbai, discussing disruptive trends, innovation, and technologies shaping the future of healthcare and life sciences.
![Scale-Up Health 2024: Disruptive Trends in Healthcare & Life Sciences](https://im.rediff.com/news/2018/feb/02health4.jpg)
Mumbai, Aug 11 (PTI) Healthcare and life sciences entrepreneurs and CEOs will deliberate on disruptive trends, innovation and technologies that drive the industry at a conference, Scale-Up Health 2024, on September 4 here, a release said on Sunday.
The annual conference on the theme of ‘IndiaNXT: Disruptive Trends for 2025 & Beyond' will focus on the global seismic shifts that have the potential to disrupt the healthcare and life sciences industry in India, Fidelity-backed investment firm Eight Roads Ventures and event organiser said in the release.
The event, backed by McKinsey & Company, will spotlight conversations on how these trends alongside innovation and disruptive technologies are redefining global healthcare delivery, accessibility and outcomes, it said.
Senior leaders and experts from the industry such as Laurus Labs Founder & CEO Satyanarayana Chava, Enzene Biosciences CEO Himanshu Gadgil and Novo Nordisk India Managing Director & Corporate Vice President Vikrant Shrotriya, among others will participate in the event.
The country has the opportunity to capitalise on some mega trends such as a new class of anti-obesity drugs and impending Biosecure legislation in the US that are driving the industry globally right now. The event will focus on trends that have the potential to disrupt the industry in 2025 and beyond, it said. PTI
The annual conference on the theme of ‘IndiaNXT: Disruptive Trends for 2025 & Beyond' will focus on the global seismic shifts that have the potential to disrupt the healthcare and life sciences industry in India, Fidelity-backed investment firm Eight Roads Ventures and event organiser said in the release.
The event, backed by McKinsey & Company, will spotlight conversations on how these trends alongside innovation and disruptive technologies are redefining global healthcare delivery, accessibility and outcomes, it said.
Senior leaders and experts from the industry such as Laurus Labs Founder & CEO Satyanarayana Chava, Enzene Biosciences CEO Himanshu Gadgil and Novo Nordisk India Managing Director & Corporate Vice President Vikrant Shrotriya, among others will participate in the event.
The country has the opportunity to capitalise on some mega trends such as a new class of anti-obesity drugs and impending Biosecure legislation in the US that are driving the industry globally right now. The event will focus on trends that have the potential to disrupt the industry in 2025 and beyond, it said. PTI
Source: PTI
Read More On:
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- GTL Infrastructure
- 2.74 (+ 2.62)
- 84886833
- Srestha Finvest
- 2.24 (+ 4.67)
- 34707853
- Ola Electric Mobilit
- 132.76 (+ 19.99)
- 27685743
- Suzlon Energy Ltd.
- 79.93 (+ 4.10)
- 27308498
- IFL Enterprises
- 1.22 (+ 4.27)
- 24757806
MORE NEWS
![Sebi Eases...](https://im.rediff.com/80-80/money/2024/aug/10sebi1.jpg)
Sebi Eases Compliance for Listed NCDs - New...
Sebi proposes amendments to simplify compliance requirements for entities with listed...
![Chandrasekaran:...](https://im.rediff.com/80-80/news/2018/jan/04modi.jpg)
Chandrasekaran: Learn From Indian Wisdom &...
Tata Group Chairman N Chandrasekaran emphasizes the importance of learning from Indian...
JSW Cement Files IPO Papers to Raise Rs 4,000...
JSW Cement has filed draft papers with Sebi for an IPO to raise Rs 4,000 crore. The IPO...